Average Co-Inventor Count = 8.15
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (12 from 2,405 patents)
2. Lycera Corporation (5 from 36 patents)
3. Goldfinch Bio, Inc. (3 from 3 patents)
4. Accent Therapeutics, Inc. (2 from 3 patents)
5. Gfb (abc), LLC (2 from 2 patents)
19 patents:
1. 12466834 - Imidazodiazepinediones and methods of use thereof
2. 12435078 - Pyridazinones and methods of use thereof
3. 12233065 - Inhibitors of RNA helicase DHX9 and uses thereof
4. 12162867 - Inhibitors of RNA helicase DHX9 and uses thereof
5. 11623930 - Imidazodiazepinediones and methods of use thereof
6. 11046690 - Pyridazinones and methods of use thereof
7. 10745364 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
8. 10654850 - Pyridazinones and methods of use thereof
9. 10221146 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
10. 9809561 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
11. 9783511 - Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease
12. 9663502 - 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease
13. 9663522 - 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof
14. 9233979 - Compounds that are ERK inhibitors
15. 9226922 - Compounds that are ERK inhibitors